Optimizing activation and culture conditions for the production of cord blood‐derived CAR ‐T and natural killer cells

Documenti analoghi

• Increased relative eosinophil counts portend neck oedema after chimeric antigen receptor‐T therapy
  di: Naokazu Nakamura, et al.
  Pubblicazione: (2025)
• Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post‐CAR‐T‐cell therapy
  di: Tomoyasu Jo, et al.
  Pubblicazione: (2025)
• Prolonged chimeric antigen receptor‐T apheresis to infusion time is associated with inferior outcomes in diffuse large B‐cell lymphoma
  di: Suguru Morimoto, et al.
  Pubblicazione: (2025)
• Nipping cytomegalovirus in the bud for umbilical cord blood transplantation
  di: Annalisa Paviglianiti
  Pubblicazione: (2024)
• Acute myeloid leukaemia with SRSF2 and BRAF mutations preceded by histiocytic proliferation in the bone marrow
  di: Minako Mori, et al.
  Pubblicazione: (2025)